High Tech Pharm Co., Ltd.
Research High Tech Pharm Co., Ltd. (106190.KQ) on Bullrun: market cap KRW 101.43B, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker106190.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 101.43B
- Dividend yield1.6%
- Financial periodQ2 2026
- RevenueKRW 23.38B
- Net incomeKRW 5.25B
- Free cash flow-KRW 3.71B
- Gross margin30.8%
Valuation Snapshot
latest market cap is KRW 101.43B; dividend yield is 1.6%.
Peer valuation comparison
Latest dividend yield is 1.57% versus a Healthcare sector median of 2.4% (34.6% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 101.43B | n/a | 1.6% | 150 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 150 KRW, yield 1.6%.
About High Tech Pharm Co., Ltd.
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is High Tech Pharm Co., Ltd.'s market cap?
High Tech Pharm Co., Ltd.'s market capitalization is KRW 101.43B.
Does High Tech Pharm Co., Ltd. pay a dividend?
High Tech Pharm Co., Ltd. has a dividend yield of 1.6%.
What does High Tech Pharm Co., Ltd. do?
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.